La amplitud de las disciplinas científicas involucradas en probar la hipótesis de los lípidos se corresponde con la distribución geográfica de los participantes. Anitschkow trabajó en Rusia, Endo descubrió la primera estatina en Japón, su desarrollo comercial por parte de Merck tuvo lugar en los EE. UU. y la evidencia del beneficio de reducir el colesterol provino de ensayos realizados en Escandinavia y el Reino Unido. El metanálisis posterior de estos ensayos con estatinas en 2005 demostró la validez de la hipótesis de los lípidos sin lugar a dudas, y la historia de cómo se produjo todo esto y su impacto en las políticas de salud y la práctica médica se recuerda aquí en "Resolving the Cholesterol Controversy".
Breve descrição
A amplitude das disciplinas científicas envolvidas no teste da hipótese lipídica corresponde à distribuição geográfica dos participantes. Anitschkow trabalhou na Rússia, Endo descobriu a primeira estatina no Japão, seu desenvolvimento comercial pela Merck ocorreu nos EUA e evidências de benefícios na redução do colesterol vieram de testes na Escandinávia e no Reino Unido. A subseqüente meta-análise desses ensaios com estatinas em 2005 provou a validade da hipótese lipídica sem sombra de dúvida, e a história de como tudo isso aconteceu e seu impacto na política de saúde e na prática médica é relembrada aqui em "Resolvendo a controvérsia do colesterol".
Full description
This book recounts the science and scientific personalities behind the chain of discoveries upon which the lipid hypothesis of atherosclerosis was built.
The narrative covers a period of just under a hundred years, starting with Anitschkow's experiments with cholesterol-fed rabbits in 1913, and recounts the endeavours and achievements of the leading actors in this protracted scientific drama. The cast includes an extraordinarily wide variety of scientific disciplines: pathology, biophysics, epidemiology, nutrition, cardiology, lipidology, genetics; microbiology, pharmacology, and clinical trial design. Most of the scientists believed that cholesterol played a causal role in atherosclerosis and cardiovascular disease but there were some who dissented strongly from this conclusion.
The breadth of scientific disciplines involved in proving the lipid hypothesis is matched by the geographical spread of the participants. Anitschkow worked in Russia, Endo discovered the first statin in Japan, their commercial development by Merck took place in the USA and evidence of benefit from lowering cholesterol came from trials conducted in Scandinavia and the UK. The subsequent meta-analysis of these statin trials in 2005 proved the validity of the lipid hypothesis beyond any doubt, and the history of how this all came about and its impact upon health policy and medical practice is recalled here in Resolving the Cholesterol Controversy.
This website uses cookies that are necessary to deliver an enjoyable experience and ensure its correct functionality and cannot be turned off. This website permits third-party cookie use, which also cannot be turned off. Optional cookies are used to improve page performance, display targeted content, and provide analytics. By clicking, "Yes, I accept," you consent to the use of these optional cookies. Learn more